Esophageal Tumor Length – An Underestimated Predictor of Survival After Esophageal Cancer Resection

Dzhendov, T.; Sopotenski, S.; Vrachanski, D.; Tchervenyakov, A.

Esophageal Tumor Length – An Underestimated Predictor of Survival After Esophageal Cancer Resection

Acta Medica Bulgarica

Volume 49 (2022): Issue 4 (December 2022)

By:

T. Dzhendov, S. Sopotenski, D. Vrachanski and A. Tchervenyakov

Open Access

|Feb 2023

References

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
Search in Google Scholar Back to article
2. Castro C, Bosetti C, Malvezzi M, et al. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. Ann Oncol. 2014 Jan;25(1):283-90. doi: 10.1093/annonc/mdt486.
Open DOI Search in Google Scholar Back to article
3. Valerianova Z, Atanasov T. (eds.) Cancer Incidence in Bulgaria, 2016 2017. University Specialized Hospital for Active Treatment in Oncology. Bulgarian National Cancer Registry. Paradigma Publ. Sofia, 2020.
Search in Google Scholar Back to article
4. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al; CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
Open DOI Search in Google Scholar Back to article
5. Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer 2015;51:2144-57.
Search in Google Scholar Back to article
6. MB Amin, SB Edge, FL Greene, et al. eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
Search in Google Scholar Back to article
7. Hsu PK, Chen HS, Liu CC, Wu SC. Application of the Eighth AJCC TNM Staging System in Patients With Esophageal Squamous Cell Carcinoma. Ann Thorac Surg. 2018 May;105(5):1516-1522. doi: 10.1016/j.athoracsur.2017.12.032. Epub 2018 Apr 5.
Open DOI Search in Google Scholar Back to article
8. Nicholson AG, Chansky K, Crowley J, et al. Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions; Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016 Mar;11(3):300-11. doi: 10.1016/j.jtho.2015.10.008. Epub 2015 Dec 24.
Open DOI Search in Google Scholar Back to article
9. Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18.
Open DOI Search in Google Scholar Back to article
10. Zhang X, Wang Y, Jiang Y, et al. The prognostic impact of tumor length in esophageal cancer: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2018 Oct;97(43):e12902. doi: 10.1097/MD.0000000000012902.
Open DOI Search in Google Scholar Back to article
11. Zeybek A, Erdoğan A, Gülkesen KH, et al. Significance of tumor length as prognostic factor for esophageal cancer. Int Surg. 2013 Jul-Sep;98(3):234-40. doi: 10.9738/INTSURG-D-13-00075.1.
Open DOI Search in Google Scholar Back to article
12. Yendamuri S, Swisher SG, Correa AM, et al. Esophageal tumor length is independently associated with long-term survival. Cancer. 2009 Feb 1;115(3):508-16. doi: 10.1002/cncr.24062. PMID: 19117343.
Open DOI Search in Google Scholar Back to article
13. Yang J, Liu Y, Li B, et al. Prognostic significance of tumor length in patients with esophageal cancer undergoing radical resection: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 2019 Apr;98(14):e15029. doi: 10.1097/MD.0000000000015029.
Open DOI Search in Google Scholar Back to article
14. Song Z, Wang J, Lin B, Zhang Y. Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population. World J Surg Oncol. 2012 Dec 18;10:273. doi: 10.1186/1477-7819-10-273.
Open DOI Search in Google Scholar Back to article
15. Wang ZY, Jiang YZ, Xiao W, et al. Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis. BMC Cancer. 2021 Sep 3;21(1):988. doi: 10.1186/s12885-021-08728-1.
Open DOI Search in Google Scholar Back to article
16. Yordanov YP, Shef A. Hypertrophic Scars and Keloids – Contemporary Concepts and Treatment Options. Acta Medica Bulgarica 2014; 41(1): 57-74.
Search in Google Scholar Back to article

DOI: https://doi.org/10.2478/amb-2022-0038 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750

Journal RSS Feed

Language: English

Page range: 27 - 30

Submitted on: Nov 8, 2022

Accepted on: Nov 17, 2022

Published on: Feb 10, 2023

Published by: Sofia Medical University

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

esophageal carcinoma,

Related subjects:

Basic medical science,

Immunology,

Clinical medicine,

Clinical medicine, other

© 2023 T. Dzhendov, S. Sopotenski, D. Vrachanski, A. Tchervenyakov, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 49 (2022): Issue 4 (December 2022)Next article